Cited by 268Medication Adherence and ComplianceLipoproteins and Cardiovascular HealthSex and Gender in Healthcare

The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.

Gender and racial disparities in adherence to statin therapy: A meta-analysis

Lewey, Jennifer, Shrank, William H., Bowry, Ashna D.K., Kilabuk, Elaine, Brennan, Troyen A., Choudhry, Niteesh K.·2013·American Heart Journal

DOI 10.1016/j.ahj.2013.02.011

Open this paper in CoChat — free account

Abstract

Background Significant disparities exist in cardiovascular outcomes based on race/ethnicity and gender. Rates of evidence-based medication use and long-term medication adherence also appear to be lower in racial subgroups and women but have been subject to little attention. Our objective was to evaluate the effect of race/ethnicity and gender on adherence to statin therapy for primary or secondary prevention. Methods and results Studies were identified through a systematic search of MEDLINE, EMBASE, ClinicalTrials.gov, and the Cochrane Database of Systematic Reviews (through April 1, 2010) and manual examination of references in selected articles. Studies reporting on adherence to statins by men and women or patients of white and nonwhite race were included. Information on study design, adherence measurement, duration, geographic location, sample size, and patient demographics was extracted using a standardized protocol. From 3,022 potentially relevant publications, 53 studies were included. Compared with men, women had a 10% greater odds of nonadherence (odds ratio 1.10, 95% confidence interval [CI], 1.07-1.13). Nonwhite race patients had a 53% greater odds of nonadherence than white race patients (odds ratio 1.53, 95% CI 1.25-1.87). There was significant heterogeneity in the pooled estimate for gender (I(2) 0.95, P value for heterogeneity <.001) and race (I(2) 0.98, P value for heterogeneity <.001). The overall results remained unchanged in those subgroups that had significantly less heterogeneity. Conclusions Among patients prescribed statins, women and nonwhite patients are at increased risk for nonadherence. Further research is needed to identify interventions best suited to improve adherence in these populations.

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2013.02.011

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Untitled work
(2014) · Medical Entomology and Zoology · Cited by 17,633
Adherence to medication.
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Health Care Disparities
Capps, L. (2003) · JAMA · doi:10.1001/jama.290.18.2487-b · Cited by 4,558
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
A systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246

Show all 98 references

Research works printed but not linked: 1

Shalansky, 2002, Effect of number of medications on cardiovascular therapy adherence, Ann Pharmacother, 36, 1532, 10.1345/aph.1C044 · DOI · Paper page

Sorted by citations

Items 101–200 of 268

Childhood Adversity as a Predictor of Non-Adherence to Statin Therapy in Adulthood
Korhonen, M. J., Halonen, J. I., Brookhart, M. A., Kawachi, I. I., Pentti, J., Karlsson, H., Mika Kivimaki, B., & Vahtera, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127638 · Cited by 22
The Role of Gender in Cost-Related Medication Nonadherence Among Patients with Diabetes
Bhuyan, S. S., Shiyanbola, O. O., Deka, P., Isehunwa, O. O., Chandak, A. N., Huang, S. S., Wang, Y., Bhatt, J., Ning, L., Lin, W. J., et al. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.05.180039 · Cited by 21
Sex disparities in the effect of statins on lipid parameters
Hunt, N. B., Emmens, J. E., Irawati, S., de Vos, S., Bos, J. H. J., Wilffert, B., Hak, E., & de Boer, R. A. (2022) · Medicine · doi:10.1097/md.0000000000028394 · Cited by 19
Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study
Zhang, X., Ji, L., Ran, X., Su, B., Ji, Q., & Hu, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-13066-z · Cited by 22
Evolution and Outcomes of Premature Coronary Artery Disease
Smith, C. L., Seigerman, M. E., Adusumalli, S., Giri, J. S., Fiorilli, P. N., Kolansky, D. M., & Kobayashi, T. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01457-8 · Cited by 23
Gender Differences in Brain-Heart Connection
Trevisan, C., Sergi, G., & Maggi, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_61 · Cited by 20
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study)
TEMD Study Group, Bayram, F., Sönmez, A., Haymana, C., Sabuncu, T., Dizdar, O. S., Gürkan, E., Çarlıoğlu, A., Ağbaht, K., Özdemir, D., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01408-2 · Cited by 22
Preparedness for Serious Illnesses: Impact of Ethnicity, Mistrust, Perceived Discrimination, and Health Communication
Bazargan, M., Cobb, S., Assari, S., & Bazargan‐Hejazi, S. (2021) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091211036885 · Cited by 19
Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries
Youn, B., Shireman, T. I., Lee, Y., Galárraga, O., Rana, A., Justice, A. C., & Wilson, I. B. (2017) · AIDS · doi:10.1097/qad.0000000000001541 · Cited by 18
Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men
Moreno-Arellano, S., Delgado-de-Mendoza, J., & Santi-Cano, M. J. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.03.012 · Cited by 19
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
van Oortmerssen, J. A. E., Mulder, J. W. C. M., van der Bijl, M. F., Mijnster, R. J. M., Kavousi, M., & van Lennep, J. E. R. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01275-1 · Cited by 19
Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study
Barrett, E. M., Paige, E., Welsh, J., Korda, R., Joshy, G., Martin, M., & Banks, E. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101342 · Cited by 18
The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence
Ding, A., Dixon, S., Ferries, E. A., & Shrank, W. H. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.3.379 · Cited by 18
Self-citation
Impact of Medicare Part D on Racial Disparities in Adherence to Cardiovascular Medications Among the Elderly
Hussein, M., Waters, T. M., Chang, C. F., Bailey, J. E., Brown, L. M., & Solomon, D. K. (2015) · Medical Care Research and Review · doi:10.1177/1077558715615297 · Cited by 18
Medication Nonadherence: The Role of Cost, Community, and Individual Factors
Abbass, I. M., Revere, L., Mitchell, J. P., & Appari, A. (2016) · Health Services Research · doi:10.1111/1475-6773.12547 · Cited by 20
Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
Norberg, H., Sjölander, M., Glader, E., & Gustafsson, M. V. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03284-4 · Cited by 21
Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men
Zamora, A., Ramos, R., Comas‐Cufí, M., García-Gil, M., Martí‐Lluch, R., Plana, N., Alves‐Cabratosa, L., Ponjoan, A., Rodríguez-Borjabad, C., Ibarretxe, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-27963-z · Cited by 18
Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study
Sandfort, V., Bluemke, D. A., Vargas, J. D., Brinker, J., Gerstenblith, G., Kickler, T. S., Zheng, G., Li, J., Chen, S., Lai, H. C., et al. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000282 · Cited by 17
Self-reported medication nonadherence predicts cholesterol levels over time
Blalock, D. V., Zullig, L. L., Bosworth, H. B., Taylor, S. S., & Voils, C. I. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.01.010 · Cited by 17
Factors Associated with Adherence to Transdermal Nicotine Patches within a Smoking Cessation Effectiveness Trial
Handschin, J., Hitsman, B. L., Blazekovic, S., Veluz‐Wilkins, A. K., Wileyto, E. P., Leone, F. T., Ashare, R. L., & Schnoll, R. A. (2017) · The Journal of Smoking Cessation · doi:10.1017/jsc.2017.2 · Cited by 17
The Health Costs of Cost-SharingPreprint
Chandra, A., Flack, E., & Obermeyer, Z. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3801882 · Cited by 18
Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD
Hess, C. N., Baumgärtner, I., Anand, S. S., Nehler, M. R., Patel, M. R., Debus, E. S., Szarek, M. J., Capell, W. H., Muehlhofer, E., Berkowitz, S. D., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024655 · Cited by 17
Assessing the performance of group‐based trajectory modeling method to discover different patterns of medication adherence
Diop, A., Gupta, A., Mueller, S., Dron, L., Harari, O., Berringer, H., Kalatharan, V., Park, J., Mésidor, M., & Talbot, D. C. (2024) · Pharmaceutical Statistics · doi:10.1002/pst.2365 · Cited by 16
Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study
Rea, F., Mella, M., Compagnoni, M. M., Cantarutti, A., Merlino, L. G., Mancia, G., & Corrao, G. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002222 · Cited by 16
Psychosocial phenotyping as a personalization strategy for chronic disease self-management interventions.
Kim, M. T., Radhakrishnan, K., Heitkemper, E., Choi, E., & Burgermaster, M. (2021) · PubMed · Cited by 20
Challenges in Optimizing Lipid Management in Women
Peterson, K., Kaur, G., Gianos, E., Mookherjee, S., Poli, K. A., Sidhu, M. S., & Lyubarova, R. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07273-0 · Cited by 19
Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting
Osula, D., Wu, B., Schesing, K. B., Das, S. R., Moss, E., Alvarez, K., Clark, C., Halm, E. A., Brown, N. J., & Vongpatanasin, W. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027099 · Cited by 15
Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database
Ramírez‐Morros, A., Franch‐Nadal, J., Real, J., Gratacòs, M., & Mauricio, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082196 · Cited by 15
Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base
Halava, H., Westerlund, H., Korhonen, M. J., Pentti, J., Mika Kivimaki, B., Kjeldgård, L., Alexanderson, K. A. E., & Vahtera, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130901 · Cited by 16
Statin Prescription for Patients With Atherosclerotic Cardiovascular Disease from National Survey Data
Vatcheva, K. P., Aparicio, V., Araya, A., Gonzalez, E., & Laing, S. T. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.03.048 · Cited by 15
Utilizing Implementation Science to Bridge Cerebrovascular Health Disparities: a Local to Global Perspective
Sarfo, F. S., & Ovbiagele, B. I. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01193-8 · Cited by 14
Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease
Goldstein, K. M., Stechuchak, K. M., Zullig, L. L., Oddone, E. Ž., Olsen, M. K., McCant, F., Bastian, L. A., Batch, B. C., & Bosworth, H. B. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.5739 · Cited by 12
Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
Al-Zakwani, I. S., Al-Mahruqi, F., Al‐Rasadi, K., Shehab, A. M., Almahmeed, W. A., Arafah, M., Al-Hinai, A. T., Tamimi, O. A., Alawadhi, M., & Santos, R. D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0667-y · Cited by 12
Adherence to Triple-Free-Drug Combination Therapies Among Patients With Cardiovascular Disease
Lombardi, N., Crescioli, G., Simonetti, M., Marconi, E., Vannacci, A., Bettiol, A., Parretti, D., Cricelli, C. A., & Lapi, F. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.036 · Cited by 12
Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring–assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation
Shiga, T., Kimura, T., Fukushima, N., Yoshiyama, Y., Iwade, K., Mori, F., Ajiro, Y., Haruta, S., Yamada, Y., Sawada, E., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.011 · Cited by 12
Natural language processing to identify reasons for sex disparity in statin prescriptions
Witting, C., Azizi, Z., Gomez, S. E., Zammit, A., Sarraju, A., Ngo, S., Hernandez-Boussard, T., & Rodriguez, F. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100496 · Cited by 10
Exploring treatment effect heterogeneity of a PROMs alert intervention in knee and hip arthroplasty patients: A causal forest application
Langenberger, B., Steinbeck, V., Schöner, L., Busse, R., Pross, C. M., & Kuklinski, D. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107118 · Cited by 12
Older Statin Initiators in Finland—Cardiovascular Risk Profiles and Persistence of Use
Upmeier, E., Korhonen, M. J., Rikala, M., Helin‐Salmivaara, A., & Huupponen, R. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6517-x · Cited by 13
Interventions to Improve Medication Adherence in Ethnically Diverse Patients: A Narrative Systematic Review
Singh, P., LeBlanc, P., & King‐Shier, K. M. (2021) · Journal of Transcultural Nursing · doi:10.1177/10436596211017971 · Cited by 12
Immunity-to-Change: Are Hidden Motives Underlying Patient Nonadherence to Chronic Disease Medications?
Krousel-Wood, M., Kegan, R., Whelton, P., & Lahey, L. (2014) · American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000310 · Cited by 10
The women’s heart health programme: a pilot trial of sex-specific cardiovascular management
Low, T. T., Chan, S. P., Wai, S. H., Ang, Z., Kyu, K., Lee, K. Y., Ching, A., Comer, S., Tan, N. Q. P., Thong, E. G. H. E., et al. (2018) · BMC Women s Health · doi:10.1186/s12905-018-0548-6 · Cited by 12
Associations Between Personality Functioning, Childhood Trauma and Non-adherence in Cardiovascular Disease: A Psychodynamically-Informed Cross-Sectional Study
Haller, K., Fritzsche, S., Kruse, I., O′Malley, G., Ehrenthal, J. C., & Stamm, T. J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.913081 · Cited by 12
Sex Differences in Nonadherence to Secondary Stroke Prevention Medications Among Patients With First‐Ever Ischemic Stroke
Chen, C., Reeves, M. J., Farris, K. B., Morgenstern, L. B., & Lisabeth, L. D. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036409 · Cited by 11
Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA
Geary, L., Aronius, J., Wettermark, B., Hasselström, J., Sjöborg, B., & von Euler, M. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12936 · Cited by 11
Impact of Adherence, Patient Perception, and Knowledge to Statin Therapy – A Cross-Sectional Study
Umarje, S. P., James, N. M., Dave, P., Raut, A., & Pandey, N. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_120_21 · Cited by 11
Multiple-domain Versus Single-domain Measurements of Socioeconomic Status (SES) for Predicting Nonadherence to Statin Medications
Alsabbagh, M. W., Lix, L. M., Eurich, D. T., Wilson, T. W., & Blackburn, D. F. (2015) · Medical Care · doi:10.1097/mlr.0000000000000468 · Cited by 11
Geschlechterspezifische Aspekte kardiovaskulärer Erkrankungen
Baessler, A., Bauer, P., Becker, M., Berrisch-Rahmel, S., Goldmann, B. U., Grünig, E., Hamm, C., Meder, B., Kindermann, I., Ong, P., et al. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00694-9 · Cited by 11
Higher long-term adherence to statins in rural patients at high atherosclerotic risk
Peverelle, M., Baradi, A., Paleri, S., Lee, Y. S., Sultani, R., Toukhsati, S. R., Hare, D. L., Janus, E. D., & Wilson, A. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.11.004 · Cited by 10
Identifying adherent patients to newly initiated statins using previous adherence to chronic medications
Majd, Z., Mohan, A., Paranjpe, R., & Abughosh, S. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.2.186 · Cited by 12
A multistate transition model for statin‐induced myopathy and statin discontinuation
Zhu, Y., Chiang, C., Wang, L., Brock, G. N., Milks, M. W., Cao, W., Zhang, P., Zeng, D., Donneyong, M. M., & Li, L. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12691 · Cited by 10
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert
Qato, D. M., Trivedi, A. N., Mor, V., & Dore, D. D. (2016) · Medical Care · doi:10.1097/mlr.0000000000000502 · Cited by 10
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms
Petry, N., Baye, J. F., Frear, S., Jacobsen, K., Massmann, A., Schultz, A., Heukelom, J. V., & Christensen, K. D. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0055 · Cited by 10
One-year statin persistence and adherence in adults with HIV in the United States
Crockett, K. B., Wen, Y. R., Overton, E. T., Jackson, E. A., Rosenson, R. S., Muntner, P., & Colantonio, L. D. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.11.001 · Cited by 9
Hypertension and Health Behaviors in Females Across the Lifespan
Krousel-Wood, M. A. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000515 · Cited by 9
Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data
Krumme, A. A., Sanfélix‐Gimeno, G., Franklin, J. M., Isaman, D. L., Mahesri, M., Matlin, O. S., Shrank, W. H., Brennan, T. A., Brill, G. E., & Choudhry, N. K. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-011015 · Cited by 10
Self-citation
Statin use, high cholesterol and prostate cancer progression; results from HCaP‐NC
Allott, E. H., Farnan, L., Steck, S. E., Song, L., Arab, L., Su, L. J., Fontham, E. T. H., Mohler, J. L., & Bensen, J. T. (2018) · The Prostate · doi:10.1002/pros.23644 · Cited by 9
Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review
de Jong, M., Peters, S. A. E., de Ritter, R., Kallen, C., Sep, S. J. S., Woodward, M., Stehouwer, C. D. A., Bots, M. L., & Vos, R. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.617902 · Cited by 9
Sex-based utilization of guideline recommended statin therapy and cardiovascular disease outcomes: Data from a multisite healthcare network primary prevention cohort
Koczo, A., Brickshawana, A., Zhu, J., Thoma, F. W., Countouris, M. E., Berlacher, K. L., Gulati, M., Michos, E. D., Reís, S. E., Mulukutla, S. R., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100667 · Cited by 7
Health inequalities in secondary prevention
Oertelt‐Prigione, S., & Maas, A. H. E. M. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317703767 · Cited by 8
Factors Affecting Adherence to Lipid-lowering Drugs: A Scoping Review
Said, A. H., Rahim, I. S. A., Zaini, N. A. M., & Nizam, N. I. B. S. (2022) · Oman Medical Journal · doi:10.5001/omj.2023.67 · Cited by 10
Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance program
Minhas, D., Marder, W., Hassett, A. L., Zick, S. M., Gordon, C., Harlow, S. D., Wang, L., Barbour, K. E., Helmick, C. G., McCune, W. J., et al. (2023) · Lupus · doi:10.1177/09612033231186113 · Cited by 8
Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study
Şen, T. (2024) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2024.4218 · Cited by 8
Medication adherence, recall periods and factors affecting it: A community‐based assessment on patients with chronic diseases in urban slums
Atal, S., Ray, A., Ahmed, S. N., Singh, P., Fatima, Z., Sadasivam, B., Pakhare, A. P., Joshi, A., & Joshi, R. P. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14316 · Cited by 10
Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients
Paranjpe, R., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., & Abughosh, S. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.03.011 · Cited by 10
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study
Bandiera, C., Lam, L., Locatelli, I., Dotta-Celio, J., Duarte, D., Wuerzner, G., Pruijm, M. T., Zanchi, A., & Schneider, M. P. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00898-7 · Cited by 9
Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents
Hiles, M., Simmons, A., Hilleman, D. E., Gibson, C., & Backes, J. M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.08.021 · Cited by 9
Sex/Gender Disparities in Randomized Controlled Trials of Statins: The Impact of Awareness Efforts
Farahani, P. (2014) · Clinical and investigative medicine · doi:10.25011/cim.v37i3.21383 · Cited by 8
Avrupa İnme için Eylem Planı 2018-2030
Norrving, B. G., Barrick, J., Dávalos, A., Dichgans, M., Cordonnier, C., Guekht, A. B., Kutluk, K., Mikulík, R., Wardlaw, J. M., Richard, E., et al. (2019) · Turkish Journal of Cerebrovascular Diseases · doi:10.5505/tbdhd.2019.94834 · Cited by 8
Monoclonal Anti-PCSK9 Antibodies: Real-World Data
Guidotti, G., Liberati, V., Sorrentino, A., Lotti, E., Crudele, F., Rogolino, A. A., Sammartino, A., Slanzi, M., Gori, A. M., Marcucci, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154543 · Cited by 7
Associations between sex, race/ethnicity, and age and the initiation of chronic high‐risk medication in US older adults
Jungo, K. T., Choudhry, N. K., Chaitoff, A. M., & Lauffenburger, J. C. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19173 · Cited by 7
Self-citation
Medication Adherence in Secondary Prevention Post-Myocardial Infarction
Valle, J. A., & Ho, P. M. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0349-7 · Cited by 7
Pharmacoequity measurement framework: A tool to reduce health disparities
Patel, P. M., Essien, U. R., & Happe, L. E. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.2.214 · Cited by 6
Coronary artery surgery outcome differences by sex
Rizvanovic, S., Arnreiter, M., Florian, A., & Sandner, S. E. (2025) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-025-01958-z · Cited by 6
Differential Outcomes for African-American Women with Cardiovascular Complications of Pregnancy
Fitzsimmons, E., Arany, Z. P., Howell, E. A., & Lewey, J. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00863-5 · Cited by 8
Self-citation
Sex specific analysis of patients with and without reported statin intolerance referred to a specialized outpatient lipid clinic
Muck, M. A., Fischer, M., Hamerle, M., Strack, C., Holzhaeuer, M., Pfeffer, D., Hubauer, U., Maier, L. S., & Baessler, A. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00642-y · Cited by 7
Statin adherence improves with age and subsequent treatment sequences: A retrospective cohort study using Proportion of Days Covered (PDC)
Tichopád, A., Donin, G., Zigmond, J., Ráfl, J., Rybář, M., Šedová, P., & Vrablı́k, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325293 · Cited by 7
Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity
Singh, C., Valero, D. J., Nisar, J., Ramirez, J. I. T., Suchak, K. K., Isola, S., Hernandez, A. M. S., & Gordon, D. K. (2020) · Cureus · doi:10.7759/cureus.10965 · Cited by 6
The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial
Obońska, K., Kasprzak, M., Sikora, J., Obońska, E., Racki, K., Goździkiewicz, N., Krintus, M., & Kubica, J. (2017) · Trials · doi:10.1186/s13063-017-2047-8 · Cited by 6
Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary Syndrome
Bavishi, A. A., Howard, T. M., Kim, J. P., Hiramoto, B. A., Pierce, J. B., Mendapara, P., Alhalel, J., Wu, H.-W., Srdanovic, N., & Stone, N. J. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.034 · Cited by 6
A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans
Chinthammit, C., Axon, D. R., Anderson, S., Lott, B. E., Taylor, A. M., Pickering, M. K., Black, H. L., Warholak, T. L., & Campbell, P. J. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.09.005 · Cited by 6
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?
Maitra, N. S., Mahtta, D., Navaneethan, S. D., Vaughan, E. M., Kochar, A., Gulati, M., Levine, G. N., Petersen, L. A., & Virani, S. S. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01694-5 · Cited by 7
Medikamentöse Sekundärprävention bei Frauen und Männern mit koronarer Herzkrankheit in Deutschland zwischen 1997–1999 und 2008–2011 – Trendanalyse mit Daten zweier bundesweiter Gesundheitssurveys
Knopf, H. C., Busch, M. A., Du, Y., Grams, D., Scheidt‐Nave, C., & Sarganas, G. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-02975-1 · Cited by 6
“Inclisiran: Early LDL-C target achievement in a real-life population”
Briani, F., Bagli, M., Venturi, G., Bacchion, F., & Mugnolo, A. (2025) · Atherosclerosis Plus · doi:10.1016/j.athplu.2025.01.001 · Cited by 5
Retrospective cross sectional analysis of demographic disparities in outcomes of CPR performed by EMS providers in the United States
Hill, T., Weber, T., Roberts, M., Garzón, H., Fraga, A., Wetterer, C., & Puglisi, J. L. (2021) · JRSM Cardiovascular Disease · doi:10.1177/20480040211000619 · Cited by 5
Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry
Ganokroj, P., Muanpetch, S., Deerochanawong, C., Phimphilai, M., Leelawattana, R., Thongtang, N., Krittayaphong, R., Anthanont, P., Vathesatogkit, P., Sriphrapradang, C., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64081 · Cited by 5
Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men
Gijsberts, C. M., Santema, B. T., Asselbergs, F. W., de Kleijn, D. P. V., Voskuil, M., Agostoni, P., Cramer, M. J., Vaartjes, I. C. H., Hoefer, I. E., Pasterkamp, G., et al. (2015) · Angiology · doi:10.1177/0003319715604762 · Cited by 5
Statin Use and Breast Cancer Prognosis in Black and White Women
Leiter, A., Bickell, N. A., LeRoith, D., Nayak, A., Feldman, S. M., Friedman, N. B., Estabrook, A., King, T. A., Fei, K., Franco, R., et al. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0312-7 · Cited by 5
Disparities in Secondary Prevention of Atherosclerotic Heart Disease After Coronary Artery Bypass Grafting in Northern Plains American Indians
Kruger, H., Zumwalt, C. M., Guenther, R., Jansen, R. J., Warne, D. K., & Dyke, C. (2019) · Health Equity · doi:10.1089/heq.2019.0030 · Cited by 5
Gender Differences in Brain-Heart Connection
Trevisan, C., Sergi, G., & Maggi, S. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_61-1 · Cited by 5
Understanding Study Drug Discontinuation Through EUCLID
Weissler, E. H., Mulder, H. S., Rockhold, F. W., Baumgärtner, I., Norgren, L., Blomster, J., Katona, B. G., Fowkes, F. G. R., Mahaffey, K. W., Bonaca, M. P., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.947645 · Cited by 5
Primary and Secondary Cardiovascular Prevention Among First Nations Peoples With Type 2 Diabetes in Canada: Findings From the FORGE AHEAD Program
Pace, R., Harris, S. B., Parry, M. J. E., & Zaran, H. (2020) · CJC Open · doi:10.1016/j.cjco.2020.07.004 · Cited by 4
Rosuvastatin exposure in female Wistar rats alters uterine contractility and do not show evident (anti)estrogenic effects
de Barros, J. W. F., Silva, P. V. E., da Silva, G. V., da Silva, K. P., Borges, C. D. S., Mueller, A. N., Valencise, L., Pupo, A. S., & Kempinas, W. D. G. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1919139 · Cited by 4
Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions
Lawal, K. O., Nilan, L., Amenta, J. N., McGuinness, J. E., Kukafka, R., & Crew, K. D. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-23-0181 · Cited by 4
Clinician use of the Statin Choice Shared Decision-making Encounter Tool in a Major Health System
Martinez, K. A., Montori, V. M., Rodríguez, F., Tereshchenko, L. G., Kovach, J. D., Hurwitz, H., & Rothberg, M. B. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08597-3 · Cited by 4
Cardiovascular medication adherence testing in patients living with HIV : A single‐centre observational study
Nazareth, J., Adebayo, A., Fahad, M., Karim, H., Pan, D., Sze, S., Martin, C. A., Minhas, J. S., Bernieh, D., Osman, H., et al. (2024) · HIV Medicine · doi:10.1111/hiv.13715 · Cited by 4
Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics
Phelps, G. A., Qiao, Y., Buckley, M. G., Wang, J., Li, M., Bhuyan, S. S., & Chisholm‐Burns, M. A. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.07.013 · Cited by 4
Cardiovascular Disease and Mental Distress Among Ethnic Groups in Kyrgyzstan
Azfar, H. S., Dzhusupov, K. O., Orru, H., Nordin, S., Nordin, M., & Orru, K. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.489092 · Cited by 4
Length of Stay and Short-Term Outcomes in Patients with ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: Insights from the China Acute Myocardial Infarction Registry
Lv, J., Zhao, Q., Yang, J., Gao, X., Zhang, X., Ye, Y., Dong, Q., Fu, R., Sun, H., Yan, X., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s330379 · Cited by 4
Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the PharmLines initiative
Irawati, S., Emmens, J. E., de Vos, S., Bos, J., de Boer, R. A., & Hak, E. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1984222 · Cited by 4
Systematic review on sex differences for drug use after stroke
Perrier, J., Renard, M., Pariente, A., & Bezin, J. (2022) · Therapies · doi:10.1016/j.therap.2022.11.007 · Cited by 4

Authors: Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K.
Affiliations: Brigham and Women's Hospital (US)
St. Michael's Hospital (CA)
CVS Health (United States) (US)
Corresponding author: Choudhry, Niteesh K.
ORCID: Lewey, Jennifer
Choudhry, Niteesh K.
Venue: American Heart Journal
Publisher: Elsevier BV
Published: 2013-05
Volume: 165
Issue: 5
Pages: 665-678.e1
ISSN: 0002-8703 (ISSN-L)
DOI: 10.1016/j.ahj.2013.02.011
OpenAlex: W2100554124
Cited by: 267
References: 98
Citations by year: 2026: 14 · 2025: 22 · 2024: 17 · 2023: 13 · 2022: 26 · 2021: 26 · 2020: 27 · 2019: 21 · 2018: 16 · 2017: 21 · 2016: 22 · 2015: 20 · 2014: 19 · 2013: 3
FWCI: 2.82
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: American Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
Keywords: statin therapy, medication adherence, non-compliance, gender disparities, racial disparities, ethnic minorities, women, cardiovascular disease prevention, secondary prevention, health disparities
MeSH terms: Cardiovascular Diseases, Humans, Morbidity, Sex Factors, Global Health, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Racial Groups, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gender and racial disparities in adherence to statin therapy: A meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks